vimarsana.com

Page 2 - மையம் க்கு இனப்பெருக்கம் ஆரோக்கியம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Penny Whiley wins first place in 3-Minute Thesis Faculty Final

Hudson Institute Hudson Institute PhD candidate, Penny Whiley, has won the Faculty of Medicine, Nursing and Health Sciences Three Minute Thesis Competition for her presentation explaining how her research into a very ‘importin’ protein called Importin 5 (IPO5) will identify processes that are essential for male fertility. Penny Whiley Penny won the Faculty final with her presentation, ‘Very ‘Importin’ Proteins make Very Important People!’, after placing first in the senior category of the School of Clinical Sciences competition. She will now represent the Faculty as a finalist at the Monash University 3MT Final on Wednesday, 25 August 2021 (TBC). This winner will progress to the Asia-Pacific 3MT Competition.

A common treatment for endometriosis could actually be making things worse

Last modified on Fri 2 Jul 2021 02.39 EDT It has long been believed that the best way to treat endometriosis, a chronic inflammatory condition that affects one in 10 women globally, is by performing laparoscopic surgery to remove damaged tissue from the body. But experts now say the surgery may not be as effective as once thought in relieving symptoms, and could actually be making things worse for some patients, including those who have developed separate pain conditions as a result of their endometriosis. “We find that patients don’t always get better with surgery, and those who do often feel better for a very short time,” Andrew Horne, a professor of gynaecology and reproductive sciences at Edinburgh University’s MRC Centre for Reproductive Health, tells the Guardian.

Edinburgh: EICC healthcare conference host

Covid-19 vaccine study for pregnant women launches

Date Time Covid-19 vaccine study for pregnant women launches The first Covid-19 vaccine study for women who are pregnant has been launched across the UK – with Edinburgh playing a key role in the research. The study will look to understand the safety and tolerability of the Pfizer-BioNTech jab in women who are both pregnant and healthy. It will also seek to evaluate the immunogenicity of the jab in pregnant women – the type of immune responses that the vaccine generates and their magnitude over time. Recruitment for more than 200 UK participants will begin this week. The study, which involves the University of Edinburgh’s MRC Centre for Reproductive Health, is taking place across 11 sites, including the Royal Infirmary of Edinburgh.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.